Nephros, Inc.NEPHNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank36
Studio
Year-over-Year Change

Year-over-year revenue growth rate

Percentile
P36
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-0.73%
Q3 20257.81%
Q2 2025-9.39%
Q1 202526.02%
Q4 202410.01%
Q3 20248.18%
Q2 2024-7.67%
Q1 20248.24%
Q4 2023-13.04%
Q3 20235.56%
Q2 2023-4.11%
Q1 202344.53%
Q4 20226.19%
Q3 2022-15.47%
Q2 202232.01%
Q1 2022-21.92%
Q4 20217.25%
Q3 202113.77%
Q2 2021-17.18%
Q1 202117.22%
Q4 202010.04%
Q3 202034.50%
Q2 2020-37.64%
Q1 2020-19.99%
Q4 20192.13%
Q3 201934.04%
Q2 201930.53%
Q1 20199.74%
Q4 2018-6.50%
Q3 201826.21%
Q2 201838.68%
Q1 2018-24.23%
Q4 201741.92%
Q3 20176.64%
Q2 201717.03%
Q1 2017-1.48%
Q4 201656.84%
Q3 2016-6.68%
Q2 2016-13.73%
Q1 201615.46%